[NESTLE] QoQ TTM Result on 31-Dec-2004 [#4]

Stock
[NESTLE] NESTLE (M) BHD
Announcement Date
24-Feb-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2004
Quarter
31-Dec-2004 [#4]
Profit Trend
QoQ- 0.58%
YoY- 36.07%
Quarter Report
Latest QR
Upcoming QR
NESTLE's Result
NESTLE's Financial Summary
View:
Show?
TTM Result
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
Revenue 3,064,612 3,029,761 2,978,872 2,901,183 2,843,633 2,768,260 2,688,011 9.12%
PBT 319,833 311,271 299,277 297,212 288,893 245,056 213,377 30.94%
Tax -57,509 -52,914 -57,304 -76,801 -69,761 -52,631 -44,870 17.97%
NP 262,324 258,357 241,973 220,411 219,132 192,425 168,507 34.28%
-
NP to SH 262,324 258,357 241,973 220,411 219,132 192,425 168,507 34.28%
-
Tax Rate 17.98% 17.00% 19.15% 25.84% 24.15% 21.48% 21.03% -
Total Cost 2,802,288 2,771,404 2,736,899 2,680,772 2,624,501 2,575,835 2,519,504 7.34%
-
Net Worth 410,328 405,674 461,973 368,137 321,321 311,916 375,138 6.15%
Dividend
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
Div 188,057 188,057 211,048 211,048 199,357 199,357 199,366 -3.81%
Div Payout % 71.69% 72.79% 87.22% 95.75% 90.98% 103.60% 118.31% -
Equity
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
Net Worth 410,328 405,674 461,973 368,137 321,321 311,916 375,138 6.15%
NOSH 234,473 234,493 234,504 234,482 234,541 234,523 234,461 0.00%
Ratio Analysis
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
NP Margin 8.56% 8.53% 8.12% 7.60% 7.71% 6.95% 6.27% -
ROE 63.93% 63.69% 52.38% 59.87% 68.20% 61.69% 44.92% -
Per Share
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
RPS 1,307.02 1,292.04 1,270.28 1,237.27 1,212.42 1,180.37 1,146.46 9.12%
EPS 111.88 110.18 103.18 94.00 93.43 82.05 71.87 34.28%
DPS 80.20 80.20 90.00 90.00 85.00 85.00 85.00 -3.79%
NAPS 1.75 1.73 1.97 1.57 1.37 1.33 1.60 6.15%
Adjusted Per Share Value based on latest NOSH - 234,482
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
RPS 1,306.87 1,292.01 1,270.31 1,237.18 1,212.64 1,180.49 1,146.27 9.12%
EPS 111.87 110.17 103.19 93.99 93.45 82.06 71.86 34.28%
DPS 80.20 80.20 90.00 90.00 85.01 85.01 85.02 -3.81%
NAPS 1.7498 1.73 1.97 1.5699 1.3702 1.3301 1.5997 6.15%
Price Multiplier on Financial Quarter End Date
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
Date 30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 -
Price 24.90 23.80 24.00 23.10 22.70 22.00 22.60 -
P/RPS 1.91 1.84 1.89 1.87 1.87 1.86 1.97 -2.03%
P/EPS 22.26 21.60 23.26 24.57 24.30 26.81 31.45 -20.56%
EY 4.49 4.63 4.30 4.07 4.12 3.73 3.18 25.83%
DY 3.22 3.37 3.75 3.90 3.74 3.86 3.76 -9.81%
P/NAPS 14.23 13.76 12.18 14.71 16.57 16.54 14.13 0.47%
Price Multiplier on Announcement Date
30/09/05 30/06/05 31/03/05 31/12/04 30/09/04 30/06/04 31/03/04 CAGR
Date 10/11/05 04/08/05 05/05/05 24/02/05 04/11/04 05/08/04 07/05/04 -
Price 24.60 24.90 24.50 23.60 22.60 22.00 20.80 -
P/RPS 1.88 1.93 1.93 1.91 1.86 1.86 1.81 2.55%
P/EPS 21.99 22.60 23.74 25.11 24.19 26.81 28.94 -16.71%
EY 4.55 4.42 4.21 3.98 4.13 3.73 3.46 20.01%
DY 3.26 3.22 3.67 3.81 3.76 3.86 4.09 -14.02%
P/NAPS 14.06 14.39 12.44 15.03 16.50 16.54 13.00 5.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment